Biocampus

  • Schrift vergrößern
  • Standard-Schriftgröße
  • Schriftgröße verkleinern

Axiogenesis AG

E-Mail Drucken PDF

 

Axiogenesis is an innovative and productive biotechnology company located in Cologne, Germany. Its primary focus is to develop novel assays that use differentiated embryonic stem cell (ESC)-derived cells that display normal physiological behavior. These cells are for use in pharmacology and safety screening in the pharmaceutical, chemical, and cosmetics industries. The assays detect the efficacy or toxicity of new and existing drugs and chemicals on the developing embryo and differentiated  functional tissue based on mouse ESCs.

 

 

 

axio logoAxiogenesis AG

 
Nattermannallee 1
50829 Köln

 
Telefon: +49 221 99 88 18-0
Telefax: +49 2 21 99 88 18-10
E-Mail: bernd.fronhoff@axiogenesis.com
Web: www.axiogenesis.com